<DOC>
	<DOCNO>NCT00398463</DOCNO>
	<brief_summary>This study evaluate whether add tirofiban , administer high bolus dose top aspirin clopidogrel lead low rate periprocedural myocardial infarction percutaneous coronary intervention elective patient present aspirin and/or clopidogrel resistance .</brief_summary>
	<brief_title>Study Tirofiban Administration Patients With Aspirin Clopidogrel Resistance</brief_title>
	<detailed_description>This study investigate effect treatment high bolus dosage Tirofiban ( addition Aspirin , Heparin 300mg 600mg clopidogrel ) rate periprocedural myocardial infarction compare Aspirin , Heparin ( bivalirudin ) 300mg 600mg clopidogrel alone patient resistant aspirin and/or clopidogrel . This randomized , double blind , placebo control ( bailout tirofiban rescue ) multicenter study . Enrollment last 12 36 month depend final number participate centre . The minimum follow-up 30 day index procedure .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>1 . All Patients old 18 year schedule coronary angiography and/or PCI enrol . [ Patients CKMB negative ( avoid CK washout revascularization ) also cTnI/T negative whereas highrisk feature lead patient exclusion . 2 . All consecutive patient stable unstable troponin CKMB negative coronary artery disease show aspirin clopidogrel resistance ( ACR ) enrol . These include : Patients clinical indication undergo angiography possible revascularisation . Patients ACR catheterbased coronary intervention plan base previous angiogram . 1 . Patients give inform consent life expectancy &lt; 1 year 2 . Evolving Ongoing myocardial infarction ( MI ) ( Persistence develop Q wave ST segment elevation ECG without typical chest pain typical rapid rise fall CKMB new LBBB ) patient treat physician intend use Gp IIB/IIIa inhibitor . 3 . Administration GP IIb/IIIa receptor antagonist , anticoagulation , lytic therapy previous 30 day 4 . Serum creatinine 2.5 mg/dl ( 221 micromol/L ) 5 . Ongoing bleed bleed diathesis contraindication anticoagulation increase bleed risk history bleed last 1 year 6 . Previous stroke TIA intracranial pathology last six month 7 . Major surgery trauma within previous six week 8 . Platelet count &lt; 100.000 per cubic mm HCT ,33 % Hb &lt; 11 gm/dL 9 . Subjects receive lowmolecularweight heparin within 24 hour prior randomization 10 . Subjects allergy intolerance aspirin , heparin , clopidogrel , tirofiban 11 . Patients severe hypertension ( SBP &gt; 180 mm Hg DBP &gt; 110 mm Hg ) cardiogenic shock ( SBP 80 mm Hg &gt; 30 minute ) require IABP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>tirofiban</keyword>
	<keyword>aspirin resistance</keyword>
	<keyword>clopidogrel resistance</keyword>
</DOC>